Systemic Therapy for Hereditary Breast Cancers

被引：1
|
作者：
Harvey-Jones, Elizabeth J. [1 ]
Lord, Christopher J. [2 ,3 ]
Tutt, Andrew N. J. [1 ,2 ,4 ]
机构：
[1] Breast Canc Now Res Unit, Guys Hosp Canc Ctr, London SE19RT, England
[2] Kings Coll London, City London Canc Res UK Ctr, London SE19RT, England
[3] CRUK Gene Funct Lab, Inst Canc Res, London SW36JB, England
[4] Breast Canc Now Toby Robins Breast Canc Res Ctr, Inst Canc Res, London SW36JB, England
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 01期
关键词：
Hereditary breast cancer; Chemotherapy; PARPi; Drug resistance; Biomarkers; STANDARD NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL COMPLETE RESPONSE; RANDOMIZED PHASE-II; CELL-FREE DNA; HOMOLOGOUS RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; ADJUVANT CAPECITABINE; INHIBITOR RESISTANCE; REVERSION MUTATIONS; GERMLINE MUTATIONS;
D O I：
10.1016/j.hoc.2022.08.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment options for patients with hereditary breast cancers have expanded significantly in the past 20 years. These include a new FDA-licensed approach to adjuvant therapy, olaparib, that improves OS in those with gBRCA1/2m. However, resistance to platinum-based chemotherapy and PARPi in this cohort of patients is an issue that requires considerable focus. We have discussed standard approaches to treatment, but have touched on the expanse of pre-clinical and early clinical work being undertaken which will likely shape future treatments in this field of medicine.
引用
收藏
页码：203 / 224
页数：22
相关论文
共 50 条
  • [21] Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers
    McAlarnen, Lindsey
    Stearns, Kristen
    Uyar, Denise
    [J]. APPLICATION OF CLINICAL GENETICS, 2021, 14 : 1 - 9
  • [22] Classification of hereditary breast cancers based on gene expression
    Hedenfalk I.
    Chen Y.
    Duggan D.
    Borg Å.
    Trent J.
    [J]. Nature Genetics, 2001, 27 (Suppl 4) : 58 - 58
  • [23] Systemic therapy for biliary tract cancers
    Hezel, Aram F.
    Zhu, Andrew X.
    [J]. ONCOLOGIST, 2008, 13 (04): : 415 - 423
  • [24] Hereditary predisposition to breast and other cancers: Medical novelties in 2022
    Choismier, Margaux Clement -Le
    Kasper, Edwige
    Houdayer, Claude
    Tennevet, Isabelle
    Thery, Jean-Christophe
    Parodi, Nathalie
    Branchaud, Maud
    Callonnec-L'Henaff, Francoise
    [J]. IMAGERIE DE LA FEMME, 2024, 34 (01) : 1 - 9
  • [25] Current status of prophylactic surgery for hereditary breast and gynecologic cancers
    Lynch, HT
    Casey, MJ
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (01) : 25 - 30
  • [26] Familial or sporadic?: Unexpected results in the diagnosis of hereditary breast cancers
    Schiffer, C
    Voigtländer, T
    Klaes, R
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 95 - 95
  • [27] Identification and management of hereditary breast/ovarian cancers (2004 update)
    Eisinger, F
    Bressac, B
    Castaigne, D
    Cottu, PH
    Lansac, J
    Lefranc, JP
    Lesur, A
    Nogués, C
    Pierret, J
    Puy-Pernias, S
    Sobol, H
    Tardivon, A
    Tristant, H
    Villet, R
    [J]. BULLETIN DU CANCER, 2004, 91 (03) : 219 - 237
  • [28] A new paradigm of genetic testing for hereditary breast/ovarian cancers
    Kwong, Ave
    Chen, J. W.
    Shin, Vivian Y.
    [J]. HONG KONG MEDICAL JOURNAL, 2016, 22 (02) : 171 - 177
  • [29] Assessment of SLX4 Mutations in Hereditary Breast Cancers
    Shah, Sohela
    Kim, Yonghwan
    Ostrovnaya, Irina
    Murali, Rajmohan
    Schrader, Kasmintan A.
    Lach, Francis P.
    Sarrel, Kara
    Rau-Murthy, Rohini
    Hansen, Nichole
    Zhang, Liyng
    Kirchhoff, Tomas
    Stadler, Zsofia
    Robson, Mark
    Vijai, Joseph
    Offit, Kenneth
    Smogorzewska, Agata
    [J]. PLOS ONE, 2013, 8 (06):
  • [30] Salivary Gland Cancers: Biology and Systemic Therapy
    Goyal, Gaurav
    Mehdi, Syed A.
    Ganti, Apar Kishor
    [J]. ONCOLOGY-NEW YORK, 2015, 29 (10): : 773 - 780
12345